First National Bank Of Mount Dora Trust Investment Services Trimmed By $441,600 Its Abbvie (ABBV) Position; Latin American Discovery Fund Has 0.5 Sentiment

AbbVie Inc. (NYSE:ABBV) Logo

Latin American Discovery Fund Inc (LDF) investors sentiment decreased to 0.5 in Q4 2017. It’s down -1.07, from 1.57 in 2017Q3. The ratio dropped, as 5 investment managers increased and opened new equity positions, while 10 cut down and sold their holdings in Latin American Discovery Fund Inc. The investment managers in our database now own: 3.54 million shares, down from 3.64 million shares in 2017Q3. Also, the number of investment managers holding Latin American Discovery Fund Inc in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 8 Increased: 4 New Position: 1.

First National Bank Of Mount Dora Trust Investment Services decreased Abbvie Inc (ABBV) stake by 7.61% reported in 2017Q4 SEC filing. First National Bank Of Mount Dora Trust Investment Services sold 4,600 shares as Abbvie Inc (ABBV)’s stock declined 6.31%. The First National Bank Of Mount Dora Trust Investment Services holds 55,865 shares with $5.40 million value, down from 60,465 last quarter. Abbvie Inc now has $147.83B valuation. The stock increased 0.62% or $0.57 during the last trading session, reaching $93.17. About 4.72 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since April 24, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26 before the open. They expect $1.78 earnings per share, up 39.06% or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.82 billion for 13.09 P/E if the $1.78 EPS becomes a reality. After $1.48 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. It dropped, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. 107,415 are held by Asset Advisors. State Of Alaska Department Of Revenue owns 175,563 shares or 0.41% of their US portfolio. Wade G W Inc has 0.1% invested in AbbVie Inc. (NYSE:ABBV) for 8,851 shares. Moreover, Employees Retirement Sys Of Texas has 0.41% invested in AbbVie Inc. (NYSE:ABBV). Cordasco Network invested 0.2% of its portfolio in AbbVie Inc. (NYSE:ABBV). Fred Alger Incorporated has 1.25M shares. 113,760 are held by Pinnacle Fincl Prtnrs Inc. Metropolitan Life Ins Ny invested in 0.41% or 315,606 shares. Daiwa Securities Grp Incorporated stated it has 54,097 shares. Zwj Invest Counsel accumulated 33,881 shares. Armstrong Shaw Assoc Ct owns 3.59% invested in AbbVie Inc. (NYSE:ABBV) for 43,970 shares. Valley Advisers, Pennsylvania-based fund reported 12,684 shares. 2,621 are owned by Coho Ptnrs. Bowling Portfolio Limited Liability Com reported 0.67% stake. Rnc Capital holds 3.13% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 467,186 shares.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc has $15700 highest and $6 lowest target. $103.84’s average target is 11.45% above currents $93.17 stock price. Abbvie Inc had 89 analyst reports since July 21, 2015 according to SRatingsIntel. Goldman Sachs maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, March 10. Goldman Sachs has “Buy” rating and $80 target. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Wednesday, June 8 report. Credit Suisse maintained AbbVie Inc. (NYSE:ABBV) on Thursday, July 20 with “Hold” rating. The firm earned “Buy” rating on Tuesday, August 11 by TheStreet. The stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given on Friday, October 23 by UBS. The firm earned “Underperform” rating on Tuesday, January 30 by BMO Capital Markets. On Tuesday, December 1 the stock rating was downgraded by Barclays Capital to “Equal-Weight”. Piper Jaffray maintained it with “Buy” rating and $100.0 target in Friday, September 15 report. The company was downgraded on Monday, September 25 by UBS. The rating was maintained by Jefferies with “Buy” on Friday, January 26.

Since October 30, 2017, it had 0 buys, and 12 sales for $49.35 million activity. RICHMOND TIMOTHY J. had sold 18,129 shares worth $2.15 million. On Wednesday, February 28 the insider SALEKI-GERHARDT AZITA sold $157,458. On Wednesday, February 28 the insider SEVERINO MICHAEL sold $311,684. $976,084 worth of stock was sold by GONZALEZ RICHARD A on Wednesday, February 28. ALBAN CARLOS sold 83,574 shares worth $9.57M. The insider Michael Robert A. sold $512,853. 70,928 shares were sold by CHASE WILLIAM J, worth $8.31 million on Wednesday, February 28.

Since January 1, 0001, it had 2 buys, and 0 insider sales for $87,610 activity.

City Of London Investment Management Co Ltd holds 1.78% of its portfolio in The Latin American Discovery Fund, Inc. for 2.24 million shares. 1607 Capital Partners Llc owns 179,253 shares or 0.11% of their US portfolio. Moreover, Cornerstone Advisors Inc has 0.1% invested in the company for 76,782 shares. The Connecticut-based Gramercy Funds Management Llc has invested 0.09% in the stock. Blue Bell Private Wealth Management Llc, a Pennsylvania-based fund reported 4,667 shares.

The stock decreased 0.42% or $0.05 during the last trading session, reaching $11.77. About 3,632 shares traded. The Latin American Discovery Fund, Inc. (LDF) has risen 16.78% since April 24, 2017 and is uptrending. It has outperformed by 5.23% the S&P500.

AbbVie Inc. (NYSE:ABBV) Ratings Chart